Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis | Zendy

Patrick Maison | Zendy; AnneIsabelle Tropeano | Zendy; Isabelle MacquinMavier | Zendy; Andrea Giustina | Zendy; Philippe Chanson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis

Author(s) -

Patrick Maison,

AnneIsabelle Tropeano,

Isabelle MacquinMavier,

Andrea Giustina,

Philippe Chanson

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2547

Subject(s) - acromegaly , medicine , somatostatin , context (archaeology) , cardiology , ejection fraction , diastole , blood pressure , endocrinology , heart rate , heart failure , hormone , growth hormone , paleontology , biology

Acromegaly can be complicated by cardiomyopathy. Treatment with somatostatin analogs has been shown to improve some cardiac parameters, but most published clinical trials involved few patients and were not randomized or controlled. In addition, their results are rather variable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research